Natural joint supplements for dogs have solid evidence behind them

A randomised controlled trial found that a glucosamine hydrochloride and chondroitin sulphate combination produced statistically significant improvements in pain, weight-bearing, and condition severity in dogs with naturally occurring osteoarthritis by day 70. Results were broadly comparable to carprofen. Lameness and joint mobility did not improve significantly, and the study had methodological limitations, so it is not a silver bullet, but the evidence for meaningful pain relief is real.

Devil’s claw (Harpagophytum procumbens) contains iridoid glycosides, primarily harpagoside and harpagide, which drive its analgesic and anti-inflammatory effects. These have been confirmed in both in vitro and in vivo studies. Higher-quality clinical trials in the human literature support pain reduction, though long-term veterinary-specific data are still limited. Quality matters: pharmacopeial standards require a minimum harpagoside content of 1.2%, so always cheque what you are buying.

MSM (methylsulfonylmethane) is classified as Generally Recognised As Safe (GRAS) by the FDA at up to 4 grams daily in humans, and rat toxicology studies showed no adverse effects at chronic daily doses of 1.5 g/kg for 90 days. At therapeutic doses, adverse effects in controlled trials were minor or absent. Serious toxicity has only been documented in cases of extreme overdose, many times above any sensible therapeutic amount.

Fenugreek (Trigonella foenum-graecum) seed extracts have demonstrated significant anti-inflammatory and anti-arthritic activity in rat models. Its fatty acid profile, notably linolenic and linoleic acids, appears responsible. In adjuvant-arthritis rat studies, fenugreek mucilage at 75 mg/kg produced greater edema inhibition than indomethacin at day 21, and reduced both inflammatory enzymes and pro-inflammatory cytokines. All published evidence to date is from animal studies; human clinical trials have not yet been conducted.

At therapeutic doses, serious adverse effects have not been reported in controlled trials. However, large overdoses, documented case reports involve glucosamine at 183-6,667 mg/kg and MSM at 45-4,000 mg/kg, have been associated with hepatotoxicity, acute renal injury, pancreatitis, and multiorgan dysfunction, with clinical signs appearing from 30 minutes to two days post-ingestion. Store supplements out of reach and follow label dosing carefully.

Twenty years of clinical safety data in humans document only infrequent gastrointestinal disturbances, headache, vertigo, and hypersensitivity reactions, with no serious toxicity recorded. Rat toxicology studies of aqueous-alcohol Harpagophytum procumbens extracts confirmed no serious toxic effects, though some sex-related differences in blood chemistry were noted. The European Medicines Agency recognises its traditional use. As with any active herb, quality of the extract and appropriate dosing matter.